A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Successful Management Preventing Severe Bleeding during the Perioperative Period for Subdural Hematoma by Using Recombinant Activated Coagulation Factor VII in a Case of Acquired Hemophilia A
The Kitakanto Medical Journal
Acquired hemophilia A (AHA) is a rare coagulation disorder caused by autoantibodies against coagulation factor VIII (FVIII). We report herein a case of AHA whose severe bleeding were successfully managed during the perioperative period of the surgery for chronic subdural hematoma by using recombinant activated factor VII (rFVIIa). A 54-y ear-old man was hospitalized due to cardioembolic MCA (middle cerebral artery)occlusion. He experienced severe and persistent urethral bleeding after urinarydoi:10.2974/kmj.66.211 fatcat:yxffcf764rbqxo46h6enyqglnm